White Papers

  1. Minimal Residual Disease Detection: Key Considerations For Clinical Development In Oncology
    7/9/2018

    Current MRD detection landscape, key considerations for each approach, and current advancements that will contribute to further improvements in MRD detection.

  2. Harnessing Innovative Technologies For Clinical Trials Involving Emerging And Re-Emerging Infectious Diseases
    7/5/2018

    This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola.

  3. Shifting From One Drug For All Patients To Personalized Genomics-Based Therapeutic Options
    6/28/2018

    Discover how a comprehensive personalized genomics strategy can help you identify the patients who would most likely benefit from a treatment and suffer the least side effects, ensuring the right drug is used in the right patient at the right time.

  4. Translating Data Into Insights With Bioinformatics
    6/27/2018

    Learn what bioinformatics offers to precision medicine and immuno-oncology.

  5. Minimal Residual Disease: Finding The Right Test For The New Definition Of Remission
    6/21/2018

    Measurement of Residual Disease for improved oncology trial outcomes - what factors make an MRD test most effective plus explore the pros and cons of various MRD measurement approaches.

  6. Planning And Implementing Biomarker Testing For immuno-Oncology Trials
    6/14/2018

    Exploring the challenges with the diverse clinical biomarker requirements.

  7. Clinical Road Map To Success For Over-encapsulation
    6/8/2018

    Over-encapsulation is a widely accepted blinding mechanism used throughout the clinical supplies industry, and while the process itself may appear relatively straightforward, packaging for clinical supplies is a complex process that is strictly controlled by Good Manufacturing Practices (GMP).

  8. Thriving In Value-Based Healthcare: A Guide For Cardiovascular Device Manufacturers
    5/23/2018

    Understand the challenges value-based care will present, along with success strategies for transforming them into opportunities for innovation and increased market share.

  9. How Institutions Gain Research Trial Opportunities
    5/17/2018

    How and why leading institutions have made the decision to switch from reliance on just one external IRB to partnering with multiple independent IRBs.

  10. Ten Tips For Writing Compliant Clinical Trial Participant Materials
    5/17/2018

    How to ensure participant materials are the most effective, useful, and compliant they can be.